Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 24;188(15):4123-4140.e18.
doi: 10.1016/j.cell.2025.04.039. Epub 2025 May 23.

Intra-condensate demixing of TDP-43 inside stress granules generates pathological aggregates

Affiliations

Intra-condensate demixing of TDP-43 inside stress granules generates pathological aggregates

Xiao Yan et al. Cell. .

Abstract

Cytosolic aggregation of the nuclear protein TAR DNA-binding protein 43 (TDP-43) is associated with many neurodegenerative diseases, but the triggers for TDP-43 aggregation are still debated. Here, we demonstrate that TDP-43 aggregation requires a double event. One is up-concentration in stress granules beyond a threshold, and the other is oxidative stress. These two events collectively induce intra-condensate demixing, giving rise to a dynamic TDP-43-enriched phase within stress granules, which subsequently transition into pathological aggregates. Intra-condensate demixing of TDP-43 is observed in iPS-motor neurons, a disease mouse model, and patient samples. Mechanistically, intra-condensate demixing is triggered by local unfolding of the RRM1 domain for intermolecular disulfide bond formation and by increased hydrophobic patch interactions in the C-terminal domain. By engineering TDP-43 variants resistant to intra-condensate demixing, we successfully eliminate pathological TDP-43 aggregates in cells. We suggest that up-concentration inside condensates followed by intra-condensate demixing could be a general pathway for protein aggregation.

Keywords: ALS; FTD; TDP-43; biomolecular condensate; intra-condensate demixing; neurodegenerative diseases; oxidative stress; phase separation; protein aggregation; stress granules.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests A.A.H. is a cofounder of Dewpoint Therapeutics and a member of its scientific advisory board. S.A. is a member of the scientific advisory board of Dewpoint Therapeutics.

Update of

References

    1. Iqbal K, Liu F, Gong C-X, and Grundke-Iqbal I (2010). Tau in Alzheimer disease and related tauopathies. Curr. Alzheimer Res 7, 656–664. 10.2174/156720510793611592. - DOI - PMC - PubMed
    1. Bartels T, Choi JG, and Selkoe DJ (2011). α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107–110. 10.1038/nature10324. - DOI - PMC - PubMed
    1. Ciryam P, Tartaglia GG, Morimoto RI, Dobson CM, and Vendruscolo M (2013). Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep. 5, 781–790. 10.1016/j.celrep.2013.09.043. - DOI - PMC - PubMed
    1. Cosacak MI, Bhattarai P, Bocova L, Dzewas T, Mashkaryan V, Papadimitriou C, Brandt K, Hollak H, Antos CL, and Kizil C (2017). Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain. Sci. Rep 7, 12959. 10.1038/s41598-017-13311-5. - DOI - PMC - PubMed
    1. Guo JL, Buist A, Soares A, Callaerts K, Calafate S, Stevenaert F, Daniels JP, Zoll BE, Crowe A, Brunden KR, et al. (2016). The Dynamics and Turnover of Tau Aggregates in Cultured Cells: INSIGHTS INTO THERAPIES FOR TAUOPATHIES. J. Biol. Chem 291, 13175–13193. 10.1074/jbc.M115.712083. - DOI - PMC - PubMed

LinkOut - more resources